ArticleNPJ digital medicine2026
Advancing dermatology patients' quality of life through digital health innovations: a comprehensive systematic review.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Digital health interventions (DHIs) are increasingly used in dermatology to improve patients' quality of life (QoL). This systematic review (PROSPERO: CRD420250628076) synthesized 14 studies categorized into four WHO intervention types, including telemedicine, targeted client communication, personal health tracking, and client-to-client communication, and evaluated for their effects on QoL and related psychosocial outcomes. Among telemedicine studies (n = 8), six reported non inferior or superior QoL versus in person care. Targeted client communication (n = 4) showed mixed QoL effects but improved mental health and self efficacy. Personal health tracking (n = 1) did not significantly improve QoL, while client to client communication (n = 1) provided psychosocial support. Overall, DHIs may improve QoL in dermatology, but evidence is limited by methodological heterogeneity, risk of bias, and short follow up. Future evaluations should prioritize standardized core outcome sets and integrate AI with in time adaptive interventions to deliver personalized psychological support, ensuring algorithmic equity from the outset.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.